Literature DB >> 33837971

Pretreatment clinical and genetic factors predict early post-treatment mortality in fit AML patients following induction.

J Erika Haydu1, Yael Flamand2, Rahul S Vedula1, Jurjen Versluis1, Anne Charles1, Kevin M Copson1, Richard M Stone1, Daniel J DeAngelo1, Donna Neuberg2, R Coleman Lindsley1, Marlise R Luskin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33837971      PMCID： PMC8589075          DOI： 10.1002/ajh.26188

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes.

Authors:  Sarah A Buckley; Megan Othus; Vladimir Vainstein; Janis L Abkowitz; Elihu H Estey; Roland B Walter
Journal:  Am J Hematol       Date:  2014-02-24       Impact factor: 10.047

2.  Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making.

Authors:  F Ferrara; G Barosi; A Venditti; E Angelucci; M Gobbi; F Pane; P Tosi; P Zinzani; S Tura
Journal:  Leukemia       Date:  2013-04       Impact factor: 11.528

3.  Accuracy of SIE/SIES/GITMO Consensus Criteria for Unfitness to Predict Early Mortality After Intensive Chemotherapy in Adults With AML or Other High-Grade Myeloid Neoplasm.

Authors:  Raffaele Palmieri; Megan Othus; Anna B Halpern; Mary-Elizabeth M Percival; Colin D Godwin; Pamela S Becker; Roland B Walter
Journal:  J Clin Oncol       Date:  2020-10-08       Impact factor: 44.544

4.  Somatic GATA2 mutations define a subgroup of myeloid malignancy patients at high risk for invasive fungal disease.

Authors:  Rahul S Vedula; Matthew P Cheng; Christine E Ronayne; Dimitrios Farmakiotis; Vincent T Ho; Sophia Koo; Francisco M Marty; R Coleman Lindsley; Tyler D Bold
Journal:  Blood Adv       Date:  2021-01-12

5.  Downregulation of TREM-like transcript-1 and collagen receptor α2 subunit, two novel RUNX1-targets, contributes to platelet dysfunction in familial platelet disorder with predisposition to acute myelogenous leukemia.

Authors:  Ana C Glembotsky; Dominika Sliwa; Dominique Bluteau; Nathalie Balayn; Cecilia P Marin Oyarzún; Anna Raimbault; Marie Bordas; Nathalie Droin; Iryna Pirozhkova; Valance Washington; Nora P Goette; Rosana F Marta; Rémi Favier; Hana Raslova; Paula G Heller
Journal:  Haematologica       Date:  2018-12-13       Impact factor: 9.941

6.  Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.

Authors:  Siddhartha Jaiswal; Pradeep Natarajan; Alexander J Silver; Christopher J Gibson; Alexander G Bick; Eugenia Shvartz; Marie McConkey; Namrata Gupta; Stacey Gabriel; Diego Ardissino; Usman Baber; Roxana Mehran; Valentin Fuster; John Danesh; Philippe Frossard; Danish Saleheen; Olle Melander; Galina K Sukhova; Donna Neuberg; Peter Libby; Sekar Kathiresan; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2017-06-21       Impact factor: 91.245
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.